Zymergen

OverviewSuggest Edit

Zymergen is a company that researches, develops and manufactures microbes. It develops molecules for biomedical coatings and adhesives that can be used as surgical glues either inside the body or on the skin to close a wound or to protect against infection. The Company integrates artificial intelligence algorithms and robotic genomic to search the microbial genome, discover new materials, commercialize new products and improve existing bio-manufactured products.

TypePrivate
Founded2013
HQEmeryville, CA, USMap
Websitezymergen.com
Employee Ratings2.9More
Overall CultureD-More
View Jobs

Recent NewsAll News

Latest Updates

Employees (est.) (Feb 2021)748(+3%)
Cybersecurity ratingAMore

Key People/Management at Zymergen

Josh Hoffman

Josh Hoffman

Chief Executive Officer and Co-Founder, Director
Jay Flatley

Jay Flatley

Director
Sandi Peterson

Sandi Peterson

Director
Judy Gilbert

Judy Gilbert

Chief People Officer
Aaron Kimball

Aaron Kimball

Chief Technology Officer
Matt Ocko

Matt Ocko

Director
Show more

Zymergen Office Locations

Zymergen has offices in Emeryville, Boise, Medford, Seattle and in 1 other location
Emeryville, CA, US (HQ)
5980 Horton St #105
Boise, ID, US
12426 W Explorer Dr #250
Emeryville, CA, US
5980 Horton St #105
Medford, MA, US
200 Boston Ave #2975
Seattle, WA, US
1624 4th Ave #300
千代田区, JP
4/F East Tower 1-5-1 Otemachi First Square
Show all (6)

Zymergen Financials and Metrics

Summary Metrics

Founding Date

2013

Zymergen total Funding

$876.1 m

Zymergen latest funding size

$300 m

Time since last funding

6 months ago

Zymergen investors

Goldman Sachs, Innovation Endeavors, True Ventures, SoftBank Capital, LLC, Threshold, Data Collective, AME Cloud Ventures, Two Sigma Ventures, Iconiq Capital, Baillie Gifford, Obvious Ventures, Prelude Ventures, Perceptive Advisors, Tao Capital Partners, Linden Mobile Ventures, Two Sigma Investments, Scifi VC, SoftBank Vision Fund, Data Collective DCVC, Hanwha Asset Management, Genoa Ventures, Baron Capital Group
Zymergen's latest funding round in September 2020 was reported to be $300 m. In total, Zymergen has raised $876.1 m
Show all financial metrics

Human Capital Metrics

Source: github.com
Embed Graph
Show all human capital metrics

Zymergen Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

Learn more about our premium products
SecurityScorecard logo

Zymergen Online and Social Media Presence

Zymergen's Trends

Embed Graph

Zymergen Company Culture

  • Overall Culture

    D-

    52/100

  • CEO Rating

    C

    70/100

  • Compensation

    D

    55/100

Learn more on Comparably

Zymergen News and Updates

September 09, 2020

Zymergen raised $300 million because synthetic biology is so hot right now

Zymergen, one of the companies that’s developing biomanufacturing technologies which could reshape any number of industries, said it has raised $300 million in financing yesterday. It’s part of a wave of biotech companies that TechCrunch covered in depth last month. Synthetic biology startups are gi…
September 08, 2020

Zymergen zielt mit neuer Finanzierung in Höhe von 300 Millionen USD auf die 300-Billionen-Branchen Chemie und Materialien ab

Eine der größten Deep-Tech-Investitionen des Jahres 2020 zur Einführung weiterer Produkte und Entwicklung bahnbrechender Materialien EMERYVILLE, Kalifornien, 9. September 2020 /PRNewswire/ -- Zymergen, das Unternehmen für Wissenschaft und Materialinnovation, hat heute neue Investitionen...
August 20, 2020

FMC Corporation Collaborates with Zymergen to Accelerate Discovery of Breakthrough Crop Protection Technologies

PHILADELPHIA and EMERYVILLE, Calif., Aug. 20, 2020 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading agricultural sciences company, and Zymergen, a science and material innovation company focused on rethinking biology, today announced a new collaboration focused on creating...
June 05, 2020

How California Can Lead The Global Bioeconomy: A Conversation With Zymergen CEO Josh Hoffman

If software is eating the world, biology is going to rebuild it. Zymergen has produced a billion pounds of bio-based products, and they’re just getting started. CEO and co-founder Josh Hoffman talks about the future of the bioeconomy.
April 12, 2020

Inspired By Nature, Zymergen Brews High-Performance Bio-Electronics

This simple-looking film will probably end up in your next smartphone, laptop, watch, or television. It's made by fermentation—the same process used to make bread and beer. The biomanufacturing era has begun.
March 19, 2020

As Zymergen Buys EnEvolv, Biological Manufacturing Is Ready To Transform How Industry Makes Everything From Airplanes To Air Jordans

If you could bring to market superior, sustainable materials 20% faster than your competitors, you would have a real market edge. With a boost in technology from just-acquired enEvolv, that's exactly what Zymergen hopes to achieve.
Show more

Zymergen Blogs

February 26, 2021

How Biofacturing Can Help Tackle Plastic Waste

Plastic waste is choking our landfills and polluting our water and soil. Recycling is important, but only about 9% of the world’s plastic gets recycled. The rest adds to the 6.3 billion tons of plastic waste that has accumulated across the globe. The post How Biofacturing Can Help Tackle Plastic Was…
February 24, 2021

When a Door Opens, You Go Through It: In Conversation with Zymergen CFO Enakshi Singh

We sat down with our new CFO Ena Singh to discuss her career highlights, experience with Zymergen to date, and her plans for taking the company to the next level of commercial success. The post When a Door Opens, You Go Through It: In Conversation with Zymergen CFO Enakshi Singh appeared first on Z…
February 18, 2021

Metagenomics: The superpower behind Zymergen’s biological database

A teaspoon of soil contains galaxies of Nature’s secret recipes with the potential for making anything from clothes and food to electronics and even vaccines — all with previously impossible features. Here’s how we unlock Nature’s potential to make breakthrough products. The post Metagenomics: The s…
February 12, 2021

Getting Innovative About Inclusion: Applying innovation to both products and people

When it comes to diversity, are we doing enough? Are we even doing it right? We pose these questions to Chanda Hand, Zymergen’s Diversity, Equity & Inclusion Program Manager. The post Getting Innovative About Inclusion: Applying innovation to both products and people appeared first on Zymergen.
February 05, 2021

We Make Tomorrow: In Conversation with Catherine Norbeck

Zymergen isn't content as a leader only in materials and chemicals. We're also making the workplace of tomorrow, based on shared values and empathetic leadership. Catherine Norbeck, our Director of Learning & Organizational Development, shares how. The post We Make Tomorrow: In Conversation wit…
February 03, 2021

Automation: Friend or Foe of Tomorrow’s Workforce?

As Davos contemplates the impact of automation and emerging technologies on the future workforce, we share how automation opens up new markets and frees human talent to pursue bigger, more important challenges. The post Automation: Friend or Foe of Tomorrow’s Workforce? appeared first on Zymergen.
Show more

 Zymergen Frequently Asked Questions

  • When was Zymergen founded?

    Zymergen was founded in 2013.

  • Who are Zymergen key executives?

    Zymergen's key executives are Josh Hoffman, Jay Flatley and Sandi Peterson.

  • How many employees does Zymergen have?

    Zymergen has 748 employees.

  • Who are Zymergen competitors?

    Competitors of Zymergen include iLoF, Ischemia Care and Scailyte.

  • Where is Zymergen headquarters?

    Zymergen headquarters is located at 5980 Horton St #105, Emeryville.

  • Where are Zymergen offices?

    Zymergen has offices in Emeryville, Boise, Medford, Seattle and in 1 other location.

  • How many offices does Zymergen have?

    Zymergen has 6 offices.